Clinical Trial Update: Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a five-drug anti-HIV regimen followed by treatment interruption in individuals recently infected with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED